Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
2
|
Resverlogix Corp.
|
Jun 13, 2023 12:32PM
|
Link to 2023 AGM presentation is up
|
2
|
Resverlogix Corp.
|
Jun 21, 2023 01:22PM
|
Re: OTC Expert & Grey Market Restrictions
|
2
|
Zenith Epigenetics
|
Nov 22, 2022 02:05PM
|
Re: OTC Expert & Grey Market Restrictions
|
2
|
Zenith Epigenetics
|
Nov 22, 2022 03:12PM
|
Re: Random thoughts in the vacuum of information
|
2
|
Resverlogix Corp.
|
Jul 03, 2024 03:36PM
|
Re: Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
|
2
|
Zenith Epigenetics
|
Jun 01, 2023 07:24PM
|
Re: Report Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Apr 17, 2024 07:10PM
|
Re: A Special Meeting of Shareholders?
|
2
|
Resverlogix Corp.
|
May 30, 2024 04:35PM
|
Re: Lu stepping down
|
3
|
Resverlogix Corp.
|
Apr 25, 2024 03:01PM
|
Re: So what's our ceo's next move/plan? one thought ...
|
3
|
Resverlogix Corp.
|
Apr 24, 2023 05:43PM
|
Re: TNBC no longer active?
|
3
|
Zenith Epigenetics
|
Jun 29, 2023 03:19PM
|
Re: Share Price Today
|
3
|
Resverlogix Corp.
|
Apr 06, 2023 02:57PM
|
Re: find it interesting that RVXCF.....
|
3
|
Resverlogix Corp.
|
Nov 10, 2022 12:58PM
|
Re: New SEDAR page
|
3
|
Zenith Epigenetics
|
Aug 03, 2023 11:47AM
|
Re: Add one to the list
|
3
|
Zenith Epigenetics
|
Sep 13, 2023 11:47AM
|
Re: debenture
|
3
|
Resverlogix Corp.
|
Mar 20, 2023 01:01PM
|
Re: A Special Meeting of Shareholders?
|
3
|
Resverlogix Corp.
|
May 29, 2024 11:56AM
|
Re: Zenith AGM
|
3
|
Zenith Epigenetics
|
Nov 22, 2023 02:03PM
|
Re: OTC Expert & Grey Market Restrictions
|
3
|
Zenith Epigenetics
|
Nov 22, 2022 02:29PM
|
Re: TNBC no longer active?
|
3
|
Zenith Epigenetics
|
Jun 28, 2023 12:37PM
|